We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Tiny Biosensor for Use in Brain Detects Biomarkers Tied to Traumatic Brain Injuries

By HospiMedica International staff writers
Posted on 04 Feb 2022

Scientists have successfully tested in the lab a tiny biosensor that can detect biomarkers tied to traumatic brain injuries (TBI). More...

The waterproof biosensor developed by researchers at the Ohio State University (Columbus, OH, USA) includes an “unprecedented combination of features” that may allow it to detect changes in the concentrations of various chemicals in the body and send the results to researchers in real time. The chip is flexible and thinner than a human hair, making it minimally invasive for use in the brain.

Although a biosensor such as the one the team developed could have many potential uses, the researchers were particularly focused in this study on how the sensor could be used to monitor patients with TBI. After such an injury, secondary damage can occur that can be detected by changes in sodium and potassium ion concentrations in the brain’s cerebrospinal fluid. The researchers tested the biosensor in an artificial solution they created to mimic cerebrospinal fluid and found that it could accurately detect changes in potassium and sodium ion levels that are important in TBI. In addition to the tests with the artificial cerebrospinal fluid, the team also tested the biosensor in human blood serum, in which they successfully monitored pH levels.

The chip features electronic components (known as field-effect transistors) that, upon sensing the chemical of interest, produce an electrical signal that can be detected and analyzed outside the body. Importantly, the researchers developed calibration standards that address what is called the “crosstalk” issue. While a biosensor has to be able to detect changes in the fluids in the brain, the electronics in the chip must be protected from these same fluids. A waterproof encapsulation made from a thin film of silicon dioxide – forged in temperatures above 1,000 degrees Celsius – provided high structural integrity as barrier materials in a fluid environment, the study found.

In order to find out how long the encapsulation could last in the human body, the researchers tested the material in a variety of ways, such as by placing it in heated fluids and in substances with different pH levels. Their findings suggest that waterproof encapsulation with a thickness of several hundreds of nanometers could last at least a few years at body temperature and possibly much longer. The biggest issue right now is with the chemical sensing elements, which the study suggests would work for only up to a few weeks. There are also other issues that need to be worked out before the biosensor is ready to be tested in animal models and humans. The response of biotissues to the sensor over extended period needs further study. There are still issues with crosstalk to be resolved, considering the complexity of the biosystem, and questions of how to mass produce the sensors, among other matters.

However, the study provides more evidence that these sensors have a real future in health care. The researchers believe that biosensors could be used to analyze not only ions and neurotransmitters, as in this study, but possibly peptides, proteins, nucleotide acids and other chemicals in the body. It could be a breakthrough not only for TBI, but for other chronic diseases such as Parkinson’s and Alzheimer’s disease.

“We have a long way to go from our tests in the lab, but these findings were very encouraging,” said study co-author Jinghua Li, assistant professor of materials science and engineering at Ohio State. “We believe that the capture and analysis of health data that we could achieve with biosensors are crucial to tracking long-lasting health conditions for early intervention and treatment of diseases.”

Related Links:
Ohio State University 


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Fetal Monitor
BT-380
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.